Posts by Aprazer Healthcare
The Affordability Gap in Healthcare-A Global Reality
The shifting climates, lifestyles, and genetics have increased vulnerabilities, not only the scarcity of resources, but also an increase in diseases and health disorders, both infectious and chronic. The rising disease burdens have made healthcare an indispensable need of the time....
Understanding Cancer Stages and Treatment
How Does Cancer Begin? Cancer is the outgrowth of normal cells, when the genetics of the normal cell changes and the cells continue to grow in large numbers without a halt is called cancer. The cancer cells grow excessively, occupying healthy cells...
India Leads In Anti-Cancer Medicine Manufacturing
India meets the global demand for anticancer medicines, with robust Research and Development facilities, developing new drug moieties, leading expertise, adapting the evolving regulatory standards. With the State of Art Infrastructure Indian companies contribute to investing in the latest drug development.....
How Manageable is HIV with Anti-Retroviral?
HIV has always been a menace to mankind, but the condition changes; knowing HIV is manageable, though not curable. The future of HIV treatments aims at managing HIV 100% and living a fulfilling life. Anti-retroviral therapies and combinations are increasing life expectancies and the quality of life....
All About Chemotherapy
Chemotherapy: Chemotherapy is a cancer treatment that consists of a single drug or a combination of drugs to reduce the growth of cancer. Cancer cells divide rapidly, and chemotherapy inhibits their division and propagation by damaging DNA or the signaling pathways....
Aprazer Healthcare To Build World Class Oral Solids Plant State Of The Art Manufacturing Facility
With a vision to make affordable & quality medicines Aprazer healthcare will manufacture world class oral solid drugs at state of art WHO-GMP....
Aprazer Healthcare Launched PIRFEKAST
Launch Date: 30/06/2021 Aprazer Healthcare Launched PIRFEKAST (Pirfenidone) which is a medication indicated for the treatment of idiopathic pulmonary fibrosis (IPF).....
Aprazer Healthcare Launched SUTEKAST
Launch Date: 26/02/21 Aprazer Healthcare Launched SUTEKAST (Sunitinib) which is a medication indicated for the treatment of rare cancer of the stomach, bowel, or esophagus called gastrointestinal.....
Aprazer Healthcare Launched XGRAF
Launch Date: 11/01/21 Aprazer Healthcare Launched XGRAF (Tacrolimus Capsules ) which is used for the prophylaxis of organ rejection in adults and paediatric patients receiving kidney....
Aprazer Healthcare Launched MEROAXIS
Launch Date: 19/12/20 Aprazer Healthcare Launched MEROAXIS (Meropenem Inj) which is a medication indicated for the treatment of susceptible infections including....









